Sponsor Pipeline

Vironexis Biotherapeutics Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
6
Disease Areas
Active Trials by Phase
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07192432 Gene Therapy for HER-Positive Cancer (SENTRY-HER2) HER2 Expressing Solid Tumors Recruiting
NCT06533579 Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19) B-cell Acute Lymphoblastic Leukemia Recruiting
Disease Areas
Leukemia (1) Acute Lymphoblastic Leukemia (ALL) (1) Chronic Lymphocytic Leukemia (CLL) (1) Non-Hodgkin Lymphoma (1) Follicular Lymphoma (1) Mantle Cell Lymphoma (1)
Get alerts when Vironexis Biotherapeutics Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free